Literature DB >> 11431479

A novel nuclear human poly(A) polymerase (PAP), PAP gamma.

C B Kyriakopoulou1, H Nordvarg, A Virtanen.   

Abstract

Poly(A) polymerase (PAP) is present in multiple forms in mammalian cells and tissues. Here we show that the 90-kDa isoform is the product of the gene PAPOLG, which is distinct from the previously identified genes for poly(A) polymerases. The 90-kDa isoform is referred to as human PAP gamma (hsPAP gamma). hsPAP gamma shares 60% identity to human PAPII (hsPAPII) at the amino acid level. hsPAP gamma exhibits fundamental properties of a bona fide poly(A) polymerase, specificity for ATP, and cleavage and polyadenylation specificity factor/hexanucleotide-dependent polyadenylation activity. The catalytic parameters indicate similar catalytic efficiency to that of hsPAPII. Mutational analysis and sequence comparison revealed that hsPAP gamma and hsPAPII have similar organization of structural and functional domains. hsPAP gamma contains a U1A protein-interacting region in its C terminus, and PAP gamma activity can be inhibited, as hsPAPII, by the U1A protein. hsPAPgamma is restricted to the nucleus as revealed by in situ staining and by transfection experiments. Based on this and previous studies, it is obvious that multiple isoforms of PAP are generated by three distinct mechanisms: gene duplication, alternative RNA processing, and post-translational modification. The exclusive nuclear localization of hsPAP gamma establishes that multiple forms of PAP are unevenly distributed in the cell, implying specialized roles for the various isoforms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431479     DOI: 10.1074/jbc.M104599200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Identification of a novel human nuclear-encoded mitochondrial poly(A) polymerase.

Authors:  Rafal Tomecki; Aleksandra Dmochowska; Kamil Gewartowski; Andrzej Dziembowski; Piotr P Stepien
Journal:  Nucleic Acids Res       Date:  2004-11-16       Impact factor: 16.971

Review 2.  Pre-mRNA 3'-end processing complex assembly and function.

Authors:  Serena Chan; Eun-A Choi; Yongsheng Shi
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-10-18       Impact factor: 9.957

3.  Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition.

Authors:  Krishnan Venkataraman; Kirk M Brown; Gregory M Gilmartin
Journal:  Genes Dev       Date:  2005-06-01       Impact factor: 11.361

Review 4.  RNA-specific ribonucleotidyl transferases.

Authors:  Georges Martin; Walter Keller
Journal:  RNA       Date:  2007-09-13       Impact factor: 4.942

Review 5.  Protein factors in pre-mRNA 3'-end processing.

Authors:  C R Mandel; Y Bai; L Tong
Journal:  Cell Mol Life Sci       Date:  2008-04       Impact factor: 9.261

6.  Molecular architecture of the human pre-mRNA 3' processing complex.

Authors:  Yongsheng Shi; Dafne Campigli Di Giammartino; Derek Taylor; Ali Sarkeshik; William J Rice; John R Yates; Joachim Frank; James L Manley
Journal:  Mol Cell       Date:  2009-02-13       Impact factor: 17.970

7.  BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations.

Authors:  Anindita Basak; Miroslava Hancarova; Jacob C Ulirsch; Tugce B Balci; Marie Trkova; Michal Pelisek; Marketa Vlckova; Katerina Muzikova; Jaroslav Cermak; Jan Trka; David A Dyment; Stuart H Orkin; Mark J Daly; Zdenek Sedlacek; Vijay G Sankaran
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

8.  Evidence that poly(A) binding protein C1 binds nuclear pre-mRNA poly(A) tails.

Authors:  Nao Hosoda; Fabrice Lejeune; Lynne E Maquat
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Regulation of poly(A) polymerase by 14-3-3epsilon.

Authors:  Hana Kim; June Hyung Lee; Younghoon Lee
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

10.  Mammalian GLD-2 homologs are poly(A) polymerases.

Authors:  Jae Eun Kwak; Liaoteng Wang; Scott Ballantyne; Judith Kimble; Marvin Wickens
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.